Ankasa Regenerative Therapeutics
CA - La Jolla
BiotechnologyFocus: Proprietary formulations of WNT stem cell activators fur surgical application
Ankasa Regenerative Therapeutics is a life sciences company focused on Proprietary formulations of WNT stem cell activators fur surgical application.
Cell Therapy
Funding Stage
PUBLIC
Total Funding
$19M
Open Jobs
0
Pipeline & Clinical Trials
ART352-L
Degenerative SpondylolisthesisClinical Trials (1)
NCT04378543Safety Evaluation of ART352-L in Subjects Undergoing Posterolateral Spinal Fusion
Phase 1/2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2015
Portfolio: 1 clinical trial